SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001104659-21-063934
Filing Date
2021-05-10
Accepted
2021-05-10 16:48:19
Documents
8
Period of Report
2021-05-10

Document Format Files

Seq Description Document Type Size
1 FORM 6-K tm2115493d1_6k.htm 6-K 21006
2 EXHIBIT 99.1 tm2115493d1_ex99-1.htm EX-99.1 399592
3 EXHIBIT 99.2 tm2115493d1_ex99-2.htm EX-99.2 179788
4 EXHIBIT 99.3 tm2115493d1_ex99-3.htm EX-99.3 17377
5 EXHIBIT 99.4 tm2115493d1_ex99-4.htm EX-99.4 12667
6 EXHIBIT 99.5 tm2115493d1_ex99-5.htm EX-99.5 12676
7 GRAPHIC tm2115493d1_99-2img01.jpg GRAPHIC 70208
8 GRAPHIC tm2115493d1_99-2img02.jpg GRAPHIC 88691
  Complete submission text file 0001104659-21-063934.txt   863310
Mailing Address 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7
Business Address 275 ARMAND-FRAPPIER BLVD. LAVAL A8 H7V 4A7 450-680-4500
BELLUS Health Inc. (Filer) CIK: 0001259942 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39034 | Film No.: 21907998
SIC: 2834 Pharmaceutical Preparations